
Sign up to save your podcasts
Or


What if your immune system already knows how to fight cancer… it just needs the right instructions?
In this episode of Rubin On Point, Dr. Dan Rubin sits down with Rafael Gonzalez, regenerative medicine expert and Lead Scientific Advisor for Immunocine, to unpack one of the most advanced frontiers in oncology: dendritic cell therapy.
Immunocine is focused on personalized dendritic cell immunotherapy—using an individual’s own tumor biology to help train the immune system to
recognize and target cancer with precision. This conversation breaks down how cellular therapies are shifting oncology toward personalization, immune intelligence, and biologically driven treatment strategies.
Together, they explore:
• Why dendritic cells are considered the “command center” of the immune system
• The difference between immune stimulation vs. true immune targeting
• How natural killer (NK) cells help eliminate damaged and aging cells
• The role of exosomes and cellular communication in healing and disease
• Why preserving tumor tissue may become a critical part of future cancer care
They also discuss Immunocine Preserve, a tumor tissue preservation program designed to store biopsy or surgical tumor samples for potential future use in personalized immunotherapy and emerging cellular therapies. Because many biopsies are not preserved correctly for future immune-based treatments, this process gives people the opportunity to preserve valuable tumor biology before it’s lost.
This is a deep, honest conversation about where oncology, immunology, and regenerative medicine are heading next—and what it means for people navigating a cancer diagnosis today.
🔗 Learn more about Immunocine:
Immunocine.com
🔗 Learn more about Immunocine Preserve:
ImmunocinePreserve.com
#RubinOnPoint #Immunotherapy #DendriticCellTherapy #IntegrativeOncology #CancerCare #PrecisionMedicine #ImmuneHealth
⏱ Chapters
00:00 – Intro: Cancer, resilience, and being human
01:03 – Who is Dr. Rafael Gonzalez?
02:42 – What “vaccine” really means in immunology
08:15 – What is dendritic cell therapy?
10:02 – How tumors are used to train the immune system
12:53 – Why tumor preservation matters (Immunocine Preserve)
17:06 – Why most biopsies can’t be used later
19:09 – How the treatment process works
22:49 – Natural killer (NK) cells explained
23:19 – What are “zombie cells” (senescence)?
26:33 – Anti-aging + immune system connection
28:30 – Engineering NK cells for therapy
35:56 – What are exosomes (and why they matter)?
41:06 – Risks in the exosome space
44:18 – Why NK cells may be the future
47:10 – Final thoughts on cellular therapy
By Dan Rubin, ND FABNOWhat if your immune system already knows how to fight cancer… it just needs the right instructions?
In this episode of Rubin On Point, Dr. Dan Rubin sits down with Rafael Gonzalez, regenerative medicine expert and Lead Scientific Advisor for Immunocine, to unpack one of the most advanced frontiers in oncology: dendritic cell therapy.
Immunocine is focused on personalized dendritic cell immunotherapy—using an individual’s own tumor biology to help train the immune system to
recognize and target cancer with precision. This conversation breaks down how cellular therapies are shifting oncology toward personalization, immune intelligence, and biologically driven treatment strategies.
Together, they explore:
• Why dendritic cells are considered the “command center” of the immune system
• The difference between immune stimulation vs. true immune targeting
• How natural killer (NK) cells help eliminate damaged and aging cells
• The role of exosomes and cellular communication in healing and disease
• Why preserving tumor tissue may become a critical part of future cancer care
They also discuss Immunocine Preserve, a tumor tissue preservation program designed to store biopsy or surgical tumor samples for potential future use in personalized immunotherapy and emerging cellular therapies. Because many biopsies are not preserved correctly for future immune-based treatments, this process gives people the opportunity to preserve valuable tumor biology before it’s lost.
This is a deep, honest conversation about where oncology, immunology, and regenerative medicine are heading next—and what it means for people navigating a cancer diagnosis today.
🔗 Learn more about Immunocine:
Immunocine.com
🔗 Learn more about Immunocine Preserve:
ImmunocinePreserve.com
#RubinOnPoint #Immunotherapy #DendriticCellTherapy #IntegrativeOncology #CancerCare #PrecisionMedicine #ImmuneHealth
⏱ Chapters
00:00 – Intro: Cancer, resilience, and being human
01:03 – Who is Dr. Rafael Gonzalez?
02:42 – What “vaccine” really means in immunology
08:15 – What is dendritic cell therapy?
10:02 – How tumors are used to train the immune system
12:53 – Why tumor preservation matters (Immunocine Preserve)
17:06 – Why most biopsies can’t be used later
19:09 – How the treatment process works
22:49 – Natural killer (NK) cells explained
23:19 – What are “zombie cells” (senescence)?
26:33 – Anti-aging + immune system connection
28:30 – Engineering NK cells for therapy
35:56 – What are exosomes (and why they matter)?
41:06 – Risks in the exosome space
44:18 – Why NK cells may be the future
47:10 – Final thoughts on cellular therapy